Induction of a hypertrophic growth status of coronary smooth muscle cells is associated with an overexpression of TGF-β

European Journal of Cell Biology

Volumn 81, Issue 3, 2002, Pages 138-144

  Schmidt, Annette ^a   Göpfert, Christian ^a   Vlodavsky, Israel ^b   Völker, Wolfgang ^a   Buddecke, Eckhart ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Heparin mimicking compounds; TGF isoforms; Vascular smooth muscle cells

Indexed keywords

ACETIC ACID DERIVATIVE; BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; HEPARIN; MESSENGER RNA; NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA;

ANGIOPLASTY; ANIMAL CELL; ARTERIOSCLEROSIS; ARTICLE; CELL ACTIVITY; CELL CYCLE; CELL PROLIFERATION; CELL VOLUME; CONTROLLED STUDY; DNA SYNTHESIS; GROWTH INHIBITION; HYPERTENSION; MITOGENESIS; MUSCLE HYPERTROPHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RESTENOSIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

EID: 0036230070     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-9335-00234     Document Type: Article

References (26)

1. Arterial expansive remodeling induced by high flow rates
2. Anti-proliferative activity towards vascular smooth muscle cells and receptor binding of heparin-mimicking anionic aromatic compounds
3. Vascular smooth muscle growth: Autocrine growth mechanisms
4. Mechanical load opposes angiotensin-mediated decrease in vascular alpha 1-adrenoceptors
5. Tissue angiotensin system in cardiovascular medicine. A paradigm shift?
6. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serum
7. Simple and rapid preparation of samples for PCR
8. Proliferation and subendothelial fibronectin in progressive pulmonary vascular disease
9. Vascular repair processes mediated by transforming growth factor-β
10. 2-macroglobulin inactive complex
11. Protection of transforming growth factor-β1 activity by heparin and fucoidan
12. TGF-betas and TGF-beta receptors in atherosclerosis
13. Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling and angiogenetic activity by a synthetic heparin-mimicking compound
14. Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells
15. Mimicry of biological macromolecules by polyaromatic anionic compounds
16. Myocardial growth factors
17. Endothelin, vascular hypertrophy, and hypertension
18. Differential roles of AT1 and AT2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II
19. Growth status-dependent changes of bFGF compartmentalization and heparan sulfate structure in arterial smooth muscle cells
20. Basic fibroblast growth factor controls the expression and molecular structure of heparan sulfate in corneal endothelial cells
21. Differentiation of coronary smooth muscle cells to a cell cycle-arrested hypertrophic growth status by a synthetic non-toxic heparin-mimicking compound
22. The intima. Soil for atherosclerosis and restenosis
23. Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells
24. The role of type IV collagenases in rat bladder development and obstruction
25. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation
26. Alpha1D-adrenergic receptors and mitogen-activated protein kinase mediate increased protein synthesis by arterial smooth muscle